, Tracking Stock Market Picks
Enter Symbol:
Ista Pharmaceuticals, Inc. (ISTA) [hlAlert]

down 12.84 %

Ista Pharmaceuticals, Inc. (ISTA) upgraded to Outperform with price target $15 by RBC Capital Mkts

Posted on: Wednesday,  May 4, 2011  9:25 AM ET by RBC Capital Mkts

RBC Capital Mkts rated Outperform Ista Pharmaceuticals, Inc. (NASDAQ: ISTA) on 05/04/2011, when the stock price was $10.43.
Since then, Ista Pharmaceuticals, Inc. has lost 12.85% as of 06/05/2012's recent price of $9.09.
If you would have followed this RBC Capital Mkts's recommendation on ISTA, you would have lost 12.84% of your investment in 398 days.

Ista Pharmaceuticals discovers and develops new remedies for diseases and conditions of the eye. The company's product development efforts involve mixtures of a natural enzyme called hyaluronidase. The company targets serious conditions of the eye such as vitreous hemorrhage, diabetic retinopathy, corneal opacification and keratoconus. Each of these conditions affects a significant number of patients and has limited treatment options.

RBC Capital Markets is an international corporate and investment bank that provides innovative solutions and a focused set of products and services to institutions, corporations, governments and high net worth clients around the world. With nearly 3,700 professional and support staff, we operate out of 75 offices in 15 countries and deliver our products and services through operations in Asia and Australasia, the UK and Europe and in every major North American city.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/4/2011 9:25 AM Buy
10.43 15.00
as of 12/30/2011
1 Week up  0.57 %
1 Month up  88.00 %
3 Months up  104.34 %
1 YTD down  -32.40 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/24/2011 8:25 AM Hold
6.71 8.00
2/10/2010 11:25 AM Hold
3.85 6.00
9/10/2009 8:25 AM Hold
5.51 7.00
6/29/2009 9:25 AM Hold
4.55 5.00
2/20/2009 9:25 AM Hold
1.58 3.00
4/2/2008 9:25 AM Hold
1.44 4.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy